NG00055 - CSF Aβ/ptau Summary Statistics - Deming Y et al. (2017)

Cerebrospinal fluid (CSF) tau, tau phosphorylated at threonine 181 (ptau), and Aβ₄₂ are established biomarkers for Alzheimer's disease (AD) and have been used as quantitative traits for genetic analyses.  This is the largest genome-wide association study for cerebrospinal fluid (CSF) tau/ptau levels published to date (n >3000), and identified three genome-wide hits for CSF Aβ₄₂ and five loci for ptau levels.

The p-value data is generally available to all users using the link below; however, gaining access to the complete dataset requires a formal data request.